Prostate Cancer UK becomes an affiliate of Our Future Health
1 in 8 men in the UK will be diagnosed with prostate cancer in their lifetime, making it the most common type of cancer among men. It takes the lives of over 11,500 people each year – roughly one every 45 minutes. For black men this proportion is even higher, with roughly 1 in 4 diagnosed with prostate cancer.
For over 20 years, Prostate Cancer UK have been investing in scientific research and partnerships to understand how to improve diagnosis and treatment. They are working towards for a future where no man’s life is limited by prostate cancer.
Our Future Health is joining with many of the UK’s leading health research charities who are providing valuable support and expertise to help develop Our Future Health. They will make a big impact in allowing us to ultimately change the way we prevent, detect and treat diseases.
Andrew Roddam, CEO of Our Future Health, said: “We’re delighted to be working with Prostate Cancer UK as an affiliate charity of Our Future Health. By combining their expertise with data from our research programme, we hope to find new ways to improve the lives of those affected by prostate cancer.”
Dr Matthew Hobbs, Director of Research at Prostate Cancer UK, said: “Every year in the UK over 9,500 men are diagnosed late, with prostate cancer that has already become advanced. That’s why it’s vital that we transform diagnosis of the disease as quickly as possible.
“With five million people taking part, Our Future Health could be revolutionary. This huge pool of data will help drive our future research and better understand the genetics behind prostate cancer development. We look forward to continuing to work with the Our Future Health team and other partners in this programme to drive as much benefit for men at risk of prostate cancer now and in the future.”
Read more about our partnerships.